These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6606243)

  • 1. In vivo requirements for the immune recognition of L1210 leukemia cells by allogeneic T-lymphocytes.
    Forni G; Lanfrancone L; Giovarelli M
    Tumori; 1983 Oct; 69(5):403-8. PubMed ID: 6606243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune recognition of tumor cells in vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells.
    Forni G; Landolfo S; Giovarelli M; Whitmore AC; Herberman RB
    Eur J Immunol; 1982 Aug; 12(8):664-70. PubMed ID: 6982816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous development of humoral and cellular tumor-specific immunity against L1210 mouse leukemia.
    Kawashima K; Isobe K; Nagase F; Yokochi T; Nagura E; Hasegawa Y; Morishita H; Yamada K; Nakashima I
    Leuk Res; 1985; 9(7):935-9. PubMed ID: 4021540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
    Kataoka T; Yamamoto T; Honjo K; Murayama T
    Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.
    Fuji H; Iribe H
    Cancer Res; 1986 Nov; 46(11):5541-7. PubMed ID: 3489524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The L1210 leukemia cell bears a B lymphocyte specific, non-H-2 linked alloantigen.
    Freund JG; Ahmed A; Budd RE; Dorf ME; Sell KW; Vannier WE; Humphreys RE
    J Immunol; 1976 Nov; 117(5 Pt.2):1903-5. PubMed ID: 62795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
    Fuji H; Murakami M
    J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.
    Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y
    Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. I. Preferential induction of tolerance to Mls antigens and resistance to allo-MHC antigens.
    Hosono M; Kina T; Hosokawa T; Katsura Y
    Cell Immunol; 1986 Nov; 103(1):1-10. PubMed ID: 3542233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid in vivo destruction of semi-syngeneic and allogeneic cells by nonimmunized mice as a consequence of nonidentity at H-2.
    Carlson GA; Wegmann TG
    J Immunol; 1977 Jun; 118(6):2130-7. PubMed ID: 864255
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of interleukin 1 alpha mRNA during the antigen-dependent interaction of sensitized T lymphoblasts with macrophages.
    Koide S; Steinman RM
    J Exp Med; 1988 Jul; 168(1):409-16. PubMed ID: 2969406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.
    Levy JG; Maier T; Kilburn DG
    J Immunol; 1979 Mar; 122(3):766-71. PubMed ID: 109502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on cell surface antigens of mouse leukemic and normal lymphocytes. II. Relationships between mammary leukemia, gross virus related and major histocompatibility antigens on L1210 leukemic lymphocytes.
    Steuden J; Strzadała L; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):95-7. PubMed ID: 219815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Dec; 37(12):4416-9. PubMed ID: 922733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.